These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 6383209

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
    Romand S, Pudney M, Derouin F.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
    [Abstract] [Full Text] [Related]

  • 3. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
    Sanfelice RADS, da Silva SS, Bosqui LR, Machado LF, Miranda-Sapla MM, Panagio LA, Navarro IT, Conchon-Costa I, Pavanelli WR, Almeida RS, Costa IN.
    Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro effects of sulfadiazine and its metabolites alone and in combination with pyrimethamine on Toxoplasma gondii.
    Schoondermark-van de Ven E, Vree T, Melchers W, Camps W, Galama J.
    Antimicrob Agents Chemother; 1995 Mar; 39(3):763-5. PubMed ID: 7793889
    [Abstract] [Full Text] [Related]

  • 7. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.
    Meneceur P, Bouldouyre MA, Aubert D, Villena I, Menotti J, Sauvage V, Garin JF, Derouin F.
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1269-77. PubMed ID: 18212105
    [Abstract] [Full Text] [Related]

  • 8. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
    Khan AA, Lambert LH, Remington JS, Araujo FG.
    Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro.
    Wang JL, Elsheikha HM, Li TT, He JJ, Bai MJ, Liang QL, Zhu XQ, Cong W.
    Int J Antimicrob Agents; 2019 Dec; 54(6):814-819. PubMed ID: 31479744
    [Abstract] [Full Text] [Related]

  • 11. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF, Gomes AO, Ferro EA, Napolitano DR, Mineo JR, Silva NM.
    Vet Parasitol; 2012 Jun 08; 187(1-2):44-52. PubMed ID: 22281151
    [Abstract] [Full Text] [Related]

  • 12. Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures.
    Sheffield HG, Melton ML.
    J Parasitol; 1975 Aug 08; 61(4):704-12. PubMed ID: 1165554
    [Abstract] [Full Text] [Related]

  • 13. Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.
    Blais J, Tardif C, Chamberland S.
    Antimicrob Agents Chemother; 1993 Dec 08; 37(12):2571-7. PubMed ID: 7509143
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA, Fernandes MD, Machado AS, Reis-Cunha JL, Bartholomeu DC, Almeida Vitor RW.
    Exp Parasitol; 2019 Jul 08; 202():7-14. PubMed ID: 31077733
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture.
    Derouin F, Chastang C.
    Antimicrob Agents Chemother; 1988 Mar 08; 32(3):303-7. PubMed ID: 3284458
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S, Bryskier A, Moutot M, Derouin F.
    J Antimicrob Chemother; 1995 Jun 08; 35(6):821-32. PubMed ID: 7559193
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.